Report Detail

Request for Sample of this report

Pharma & Healthcare Global Biodefense Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3023372
    • |
  • 26 February, 2019
    • |
  • Global
    • |
  • 138 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

Scope of the Report:
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The worldwide market for Biodefense is expected to grow at a CAGR of roughly 8.5% over the next five years, will reach 1390 million US$ in 2024, from 850 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Biodefense in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

Market Segment by Applications, can be divided into
US Military Market
US Civilian Market
Non - US Market

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biodefense product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biodefense, with price, sales, revenue and global market share of Biodefense in 2017 and 2018.
Chapter 3, the Biodefense competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biodefense breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Biodefense market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Biodefense sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Biodefense Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Anthrax
      • 1.2.2 Smallpox
      • 1.2.3 Botulism
      • 1.2.4 Radiation/Nuclear
      • 1.2.5 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 US Military Market
      • 1.3.2 US Civilian Market
      • 1.3.3 Non - US Market
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Emergent Biosolutions
      • 2.1.1 Business Overview
      • 2.1.2 Biodefense Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Emergent Biosolutions Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Hytest
      • 2.2.1 Business Overview
      • 2.2.2 Biodefense Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Hytest Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 GSK
      • 2.3.1 Business Overview
      • 2.3.2 Biodefense Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 GSK Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sanofi
      • 2.4.1 Business Overview
      • 2.4.2 Biodefense Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sanofi Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 PharmAthene
      • 2.5.1 Business Overview
      • 2.5.2 Biodefense Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 PharmAthene Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Bavarian Nordic
      • 2.6.1 Business Overview
      • 2.6.2 Biodefense Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Bavarian Nordic Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 SIGA Technologies
      • 2.7.1 Business Overview
      • 2.7.2 Biodefense Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 SIGA Technologies Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Arbutus Biopharma
      • 2.8.1 Business Overview
      • 2.8.2 Biodefense Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Arbutus Biopharma Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 DynPort Vaccine
      • 2.9.1 Business Overview
      • 2.9.2 Biodefense Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 DynPort Vaccine Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Xoma Corporation
      • 2.10.1 Business Overview
      • 2.10.2 Biodefense Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Xoma Corporation Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Ichor Medical Systems
      • 2.11.1 Business Overview
      • 2.11.2 Biodefense Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Ichor Medical Systems Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Aeolus Pharmaceuticals
      • 2.12.1 Business Overview
      • 2.12.2 Biodefense Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Aeolus Pharmaceuticals Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Achaogen
      • 2.13.1 Business Overview
      • 2.13.2 Biodefense Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Achaogen Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Elusys Therapeutics
      • 2.14.1 Business Overview
      • 2.14.2 Biodefense Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Elusys Therapeutics Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Dynavax Technologies
      • 2.15.1 Business Overview
      • 2.15.2 Biodefense Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Dynavax Technologies Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Cleveland BioLabs
      • 2.16.1 Business Overview
      • 2.16.2 Biodefense Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Cleveland BioLabs Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Soligenix
      • 2.17.1 Business Overview
      • 2.17.2 Biodefense Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Soligenix Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Alnylam Pharmaceuticals
      • 2.18.1 Business Overview
      • 2.18.2 Biodefense Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Alnylam Pharmaceuticals Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Biodefense Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Biodefense Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Biodefense Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Biodefense Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Biodefense Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Biodefense Market Analysis by Regions

    • 4.1 Global Biodefense Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Biodefense Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Biodefense Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Biodefense Sales and Growth Rate (2014-2019)
    • 4.3 Europe Biodefense Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Biodefense Sales and Growth Rate (2014-2019)
    • 4.5 South America Biodefense Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Biodefense Sales and Growth Rate (2014-2019)

    5 North America Biodefense by Country

    • 5.1 North America Biodefense Sales, Revenue and Market Share by Country
      • 5.1.1 North America Biodefense Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Biodefense Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Biodefense Sales and Growth Rate (2014-2019)
    • 5.3 Canada Biodefense Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Biodefense Sales and Growth Rate (2014-2019)

    6 Europe Biodefense by Country

    • 6.1 Europe Biodefense Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Biodefense Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Biodefense Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Biodefense Sales and Growth Rate (2014-2019)
    • 6.3 UK Biodefense Sales and Growth Rate (2014-2019)
    • 6.4 France Biodefense Sales and Growth Rate (2014-2019)
    • 6.5 Russia Biodefense Sales and Growth Rate (2014-2019)
    • 6.6 Italy Biodefense Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Biodefense by Country

    • 7.1 Asia-Pacific Biodefense Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Biodefense Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Biodefense Revenue and Market Share by Country (2014-2019)
    • 7.2 China Biodefense Sales and Growth Rate (2014-2019)
    • 7.3 Japan Biodefense Sales and Growth Rate (2014-2019)
    • 7.4 Korea Biodefense Sales and Growth Rate (2014-2019)
    • 7.5 India Biodefense Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Biodefense Sales and Growth Rate (2014-2019)

    8 South America Biodefense by Country

    • 8.1 South America Biodefense Sales, Revenue and Market Share by Country
      • 8.1.1 South America Biodefense Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Biodefense Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Biodefense Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Biodefense Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Biodefense Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Biodefense by Countries

    • 9.1 Middle East and Africa Biodefense Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Biodefense Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Biodefense Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Biodefense Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Biodefense Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Biodefense Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Biodefense Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Biodefense Sales and Growth Rate (2014-2019)

    10 Global Biodefense Market Segment by Type

    • 10.1 Global Biodefense Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Biodefense Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Biodefense Revenue and Market Share by Type (2014-2019)
    • 10.2 Anthrax Sales Growth and Price
      • 10.2.1 Global Anthrax Sales Growth (2014-2019)
      • 10.2.2 Global Anthrax Price (2014-2019)
    • 10.3 Smallpox Sales Growth and Price
      • 10.3.1 Global Smallpox Sales Growth (2014-2019)
      • 10.3.2 Global Smallpox Price (2014-2019)
    • 10.4 Botulism Sales Growth and Price
      • 10.4.1 Global Botulism Sales Growth (2014-2019)
      • 10.4.2 Global Botulism Price (2014-2019)
    • 10.5 Radiation/Nuclear Sales Growth and Price
      • 10.5.1 Global Radiation/Nuclear Sales Growth (2014-2019)
      • 10.5.2 Global Radiation/Nuclear Price (2014-2019)
    • 10.6 Others Sales Growth and Price
      • 10.6.1 Global Others Sales Growth (2014-2019)
      • 10.6.2 Global Others Price (2014-2019)

    11 Global Biodefense Market Segment by Application

    • 11.1 Global Biodefense Sales Market Share by Application (2014-2019)
    • 11.2 US Military Market Sales Growth (2014-2019)
    • 11.3 US Civilian Market Sales Growth (2014-2019)
    • 11.4 Non - US Market Sales Growth (2014-2019)

    12 Biodefense Market Forecast (2019-2024)

    • 12.1 Global Biodefense Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Biodefense Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Biodefense Market Forecast (2019-2024)
      • 12.2.2 Europe Biodefense Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Biodefense Market Forecast (2019-2024)
      • 12.2.4 South America Biodefense Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Biodefense Market Forecast (2019-2024)
    • 12.3 Biodefense Market Forecast by Type (2019-2024)
      • 12.3.1 Global Biodefense Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Biodefense Market Share Forecast by Type (2019-2024)
    • 12.4 Biodefense Market Forecast by Application (2019-2024)
      • 12.4.1 Global Biodefense Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Biodefense Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Biodefense . Industry analysis & Market Report on Biodefense is a syndicated market report, published as Global Biodefense Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Biodefense market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,766.60
      		4,149.90
      		5,533.20
      		3,219.00
      		4,828.50
      		6,438.00
      		544,341.60
      		816,512.40
      		1,088,683.20
      		290,684.40
      		436,026.60
      		581,368.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo